Please select an option below to help us tailor your newsletter to best suit your content interests!
At West Cancer Center, we believe the atmosphere and environment our patients receive care and treatment can be as vital in their journey as their clinical treatment. In fact, we have designed many of our locations with an arts focus. So, when Annabella Tian from Lausanne Collegiate School reached out to our Art Therapist, Paige… Read more »
West Cancer Center & Research Institute, a pioneer in radiology technology, now has a recently FDA-approved radiopharmaceutical agent: prostate-specific membrane antigen (PSMA). This agent will be imaged with our state-of-art PET/CT imaging for men diagnosed with prostate cancer. According to the American Cancer Society, 1 in 8 men will be diagnosed with prostate cancer… Read more »
According to the American Cancer Society, more than 14,000 women are expected to be diagnosed with invasive cervical cancer in 2022 with an estimated 4,280 deaths. Cervical cancer was once one of the most common causes of cancer deaths for American women, but early detection from pap smears, HPV vaccines, and new innovative… Read more »
We are so excited to announce West Cancer Center’s 7th Annual West Oncology Conference on February 25-26, 2022. A distinguished panel of speakers from both West and cancer centers across the country, will present and discuss new research findings in oncology education. Participants will be provided with updates on practice-changing data in women’s cancers, genitourinary cancers, hematological… Read more »
Oral Abstract Session: Melanoma/Skin Cancers Sunday, June 6, 2021; 8:00 AM–11:00 AM EDT 9501 Final analysis of overall survival (OS) and relapse-free-survival (RFS) in the intergroup S1404 phase III randomized trial comparing either high-dose interferon (HDI) or ipilimumab to pembrolizumab in patients with high-risk resected melanoma. KF Grossmann, M Othus, SP Patel, et al Take-Home Message The… Read more »
New technology and treatments for cancer are ever changing. Researching and providing innovative, curative therapies are a top priority at West Cancer Center. Now women managing cervical cancer will have access to MRI-guided brachytherapy treatment as an option – first available in the MidSouth, right here at West. According to the American Cancer Society, cervical… Read more »
Our West family is proud to have several of our oncologists publish research being presented at the upcoming American Society of Clinical Oncology Meeting, taking place June 4 – 8. West Cancer Center doctors Schwartzberg, Grothey, A. VanderWalde, Vaena, Vidal and ElNaggar are some of the renowned physicians being recognized at this esteemed event for… Read more »
OneR and West Cancer Physicians Give Ten Presentations at SABCS OneOncology, the national network of independent oncology practices, announced today that physicians from OneR, the OneOncology Research Network and West Cancer and Research Institute will share results from ten research studies at the San Antonio Breast Cancer Symposium® (SABCS®), an international gathering of physicians and… Read more »
Choosing the Right Biosimilar for Cancer Care The introduction of biosimilars as anticancer therapies was preceded by a period of supportive care biosimilars. Lee S. Schwartzberg, MD, FACP, describes how he and other clinicians decide which of these agents to use. Well before biosimilar anticancer agents became available, oncologists gained familiarity using biosimilars… Read more »